Cargando…
Olfactory impairment in the rotenone model of Parkinson’s disease is associated with bulbar dopaminergic D2 activity after REM sleep deprivation
Olfactory and rapid eye movement (REM) sleep deficits are commonly found in untreated subjects with a recent diagnosis of Parkinson’s disease (PD). Additionally, different studies report declines in olfactory performance during a short period of sleep deprivation. Mechanisms underlying these clinica...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4249459/ https://www.ncbi.nlm.nih.gov/pubmed/25520618 http://dx.doi.org/10.3389/fncel.2014.00383 |
_version_ | 1782346858702569472 |
---|---|
author | Rodrigues, Lais S. Targa, Adriano D. S. Noseda, Ana Carolina D. Aurich, Mariana F. Da Cunha, Cláudio Lima, Marcelo M. S. |
author_facet | Rodrigues, Lais S. Targa, Adriano D. S. Noseda, Ana Carolina D. Aurich, Mariana F. Da Cunha, Cláudio Lima, Marcelo M. S. |
author_sort | Rodrigues, Lais S. |
collection | PubMed |
description | Olfactory and rapid eye movement (REM) sleep deficits are commonly found in untreated subjects with a recent diagnosis of Parkinson’s disease (PD). Additionally, different studies report declines in olfactory performance during a short period of sleep deprivation. Mechanisms underlying these clinical manifestations are poorly understood, and impairment of dopamine (DA) neurotransmission in the olfactory bulb and the nigrostriatal pathway may have important roles in olfaction and REM sleep disturbances. Therefore, we hypothesized that modulation of the dopaminergic D2 receptors in the olfactory bulb could provide a more comprehensive understanding of the olfactory deficits in PD and REM sleep deprivation (REMSD). We decided to investigate the olfactory, neurochemical, and histological alterations generated through the administration of piribedil (a selective D2 agonist) or raclopride (a selective D2 antagonist) within the glomerular layer of the olfactory bulb, in rats subjected to intranigral rotenone and REMSD. Our findings provide evidence of the occurrence of a negative correlation (r = −0.52, P = 0.04) between the number of periglomerular TH-ir neurons and the bulbar levels of DA in the rotenone, but not sham, groups. A significant positive correlation (r = 0.34, P = 0.03) was observed between nigrostriatal DA levels and olfactory discrimination index (DI) for the sham groups, indicating that increased DA levels in the substantia nigra pars compacta (SNpc) are associated with enhanced olfactory discrimination performance. Also, increased levels in bulbar and striatal DA were induced by piribedil in the rotenone control and rotenone REMSD groups, consistent with reductions in the DI. The present evidence reinforce the idea that DA produced by periglomerular neurons, particularly the bulbar dopaminergic D2 receptors, is an essential participant in olfactory discrimination processes, as the SNpc, and the striatum. |
format | Online Article Text |
id | pubmed-4249459 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-42494592014-12-17 Olfactory impairment in the rotenone model of Parkinson’s disease is associated with bulbar dopaminergic D2 activity after REM sleep deprivation Rodrigues, Lais S. Targa, Adriano D. S. Noseda, Ana Carolina D. Aurich, Mariana F. Da Cunha, Cláudio Lima, Marcelo M. S. Front Cell Neurosci Neuroscience Olfactory and rapid eye movement (REM) sleep deficits are commonly found in untreated subjects with a recent diagnosis of Parkinson’s disease (PD). Additionally, different studies report declines in olfactory performance during a short period of sleep deprivation. Mechanisms underlying these clinical manifestations are poorly understood, and impairment of dopamine (DA) neurotransmission in the olfactory bulb and the nigrostriatal pathway may have important roles in olfaction and REM sleep disturbances. Therefore, we hypothesized that modulation of the dopaminergic D2 receptors in the olfactory bulb could provide a more comprehensive understanding of the olfactory deficits in PD and REM sleep deprivation (REMSD). We decided to investigate the olfactory, neurochemical, and histological alterations generated through the administration of piribedil (a selective D2 agonist) or raclopride (a selective D2 antagonist) within the glomerular layer of the olfactory bulb, in rats subjected to intranigral rotenone and REMSD. Our findings provide evidence of the occurrence of a negative correlation (r = −0.52, P = 0.04) between the number of periglomerular TH-ir neurons and the bulbar levels of DA in the rotenone, but not sham, groups. A significant positive correlation (r = 0.34, P = 0.03) was observed between nigrostriatal DA levels and olfactory discrimination index (DI) for the sham groups, indicating that increased DA levels in the substantia nigra pars compacta (SNpc) are associated with enhanced olfactory discrimination performance. Also, increased levels in bulbar and striatal DA were induced by piribedil in the rotenone control and rotenone REMSD groups, consistent with reductions in the DI. The present evidence reinforce the idea that DA produced by periglomerular neurons, particularly the bulbar dopaminergic D2 receptors, is an essential participant in olfactory discrimination processes, as the SNpc, and the striatum. Frontiers Media S.A. 2014-12-01 /pmc/articles/PMC4249459/ /pubmed/25520618 http://dx.doi.org/10.3389/fncel.2014.00383 Text en Copyright © 2014 Rodrigues, Targa, Noseda, Aurich, Da Cunha and Lima. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution and reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Rodrigues, Lais S. Targa, Adriano D. S. Noseda, Ana Carolina D. Aurich, Mariana F. Da Cunha, Cláudio Lima, Marcelo M. S. Olfactory impairment in the rotenone model of Parkinson’s disease is associated with bulbar dopaminergic D2 activity after REM sleep deprivation |
title | Olfactory impairment in the rotenone model of Parkinson’s disease is associated with bulbar dopaminergic D2 activity after REM sleep deprivation |
title_full | Olfactory impairment in the rotenone model of Parkinson’s disease is associated with bulbar dopaminergic D2 activity after REM sleep deprivation |
title_fullStr | Olfactory impairment in the rotenone model of Parkinson’s disease is associated with bulbar dopaminergic D2 activity after REM sleep deprivation |
title_full_unstemmed | Olfactory impairment in the rotenone model of Parkinson’s disease is associated with bulbar dopaminergic D2 activity after REM sleep deprivation |
title_short | Olfactory impairment in the rotenone model of Parkinson’s disease is associated with bulbar dopaminergic D2 activity after REM sleep deprivation |
title_sort | olfactory impairment in the rotenone model of parkinson’s disease is associated with bulbar dopaminergic d2 activity after rem sleep deprivation |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4249459/ https://www.ncbi.nlm.nih.gov/pubmed/25520618 http://dx.doi.org/10.3389/fncel.2014.00383 |
work_keys_str_mv | AT rodrigueslaiss olfactoryimpairmentintherotenonemodelofparkinsonsdiseaseisassociatedwithbulbardopaminergicd2activityafterremsleepdeprivation AT targaadrianods olfactoryimpairmentintherotenonemodelofparkinsonsdiseaseisassociatedwithbulbardopaminergicd2activityafterremsleepdeprivation AT nosedaanacarolinad olfactoryimpairmentintherotenonemodelofparkinsonsdiseaseisassociatedwithbulbardopaminergicd2activityafterremsleepdeprivation AT aurichmarianaf olfactoryimpairmentintherotenonemodelofparkinsonsdiseaseisassociatedwithbulbardopaminergicd2activityafterremsleepdeprivation AT dacunhaclaudio olfactoryimpairmentintherotenonemodelofparkinsonsdiseaseisassociatedwithbulbardopaminergicd2activityafterremsleepdeprivation AT limamarceloms olfactoryimpairmentintherotenonemodelofparkinsonsdiseaseisassociatedwithbulbardopaminergicd2activityafterremsleepdeprivation |